7 Structures of Bacterial Polysaccharides
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
B. Fragilis Is Mediated by Capsular
bioRxiv preprint doi: https://doi.org/10.1101/2020.08.19.258442; this version posted August 21, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Hemagglutination by B. fragilis is mediated by capsular 2 polysaccharides and is influenced by host ABO blood type. 3 Kathleen L. Arnolds a, Nancy Moreno-Huizar b, Maggie A. Stanislawski c, 4 Brent Palmer c, Catherine Lozupone c* 5 a Department of Microbiology, University of Colorado Anschutz Medical Campus, 6 Aurora, CO, USA [email protected] 7 b Department of Computer Science, University of Colorado Denver, Denver, CO, USA. 8 c Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, 9 CO, USA [email protected] 10 11 12 13 14 15 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.19.258442; this version posted August 21, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 16 Hemagglutination by B. fragilis is mediated by capsular polysaccharides and is 17 influenced by host ABO blood type. 18 19 Bacterial hemagglutination of red blood cells (RBCs) is mediated by 20 interactions between bacterial cell components and RBC envelope glycans 21 that vary across individuals by ABO blood type. -
Uvic Thesis Template
Insight into the Functionality of an Unusual Glycoside Hydrolase from Family 50 by Kaleigh Giles BSc, Brock University, 2011 A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of MASTER OF SCIENCE in the Department of Biochemistry and Microbiology Kaleigh Giles, 2014 University of Victoria All rights reserved. This thesis may not be reproduced in whole or in part, by photocopy or other means, without the permission of the author. ii Supervisory Committee Insight into the Functionality of an Unusual Glycoside Hydrolase from Family 50 by Kaleigh Giles BSc, Brock University, 2011 Supervisory Committee Dr. Alisdair B. Boraston, Department of Biochemistry and Microbiology Supervisor Dr. Martin J. Boulanger (Department of Biochemistry and Microbiology) Departmental Member Dr. Fraser Hof (Department of Chemistry) Outside Member iii Abstract Supervisory Committee Dr. Alisdair B. Boraston, Department of Biochemistry and Microbiology Supervisor Dr. Martin J. Boulanger, Department of Biochemistry and Microbiology Departmental Member Dr. Fraser Hof, Department of Chemistry O utside Member Agarose and porphyran are related galactans that are only found within red marine algae. As such, marine microorganisms have adapted to using these polysaccharides as carbon sources through the acquisition of unique Carbohydrate Active enZymes (CAZymes). A recent metagenome study of the microbiomes from a Japanese human population identified putative CAZymes in several bacterial species, including Bacteroides plebeius that have significant amino acid sequence similarity with those from marine bacteria. Analysis of one potential CAZyme from B. plebeius (BpGH50) is described here. While displaying up to 30% sequence identity with β-agarases, BpGH50 has no detectable agarase activity. Its crystal structure reveals that the topology of the active site is much different than previously characterized agarases, while containing the same core catalytic machinery. -
Bacteriophages Targeting Acinetobacter Baumannii Capsule
bioRxiv preprint doi: https://doi.org/10.1101/2020.02.25.965590; this version posted February 26, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 Bacteriophages targeting Acinetobacter baumannii capsule 2 induce antimicrobial resensitization 3 4 Fernando Gordillo Altamirano1*, John H. Forsyth1, Ruzeen Patwa1, Xenia Kostoulias2, Michael Trim1, Dinesh 5 Subedi1, Stuart Archer3, Faye C. Morris2, Cody Oliveira1, Luisa Kielty1, Denis Korneev1, Moira K. O’Bryan1, 6 Trevor J. Lithgow2, Anton Y. Peleg2,4, Jeremy J. Barr1* 7 8 1 School of Biological Sciences, Monash University 9 2 Biomedicine Discovery Institute and Department of Microbiology, Monash University 10 3 Monash Bioinformatics Platform, Faculty of Medicine, Nursing and Health Sciences, Monash University 11 4 Department of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University 12 13 *Corresponding authors 14 Fernando Gordillo Altamirano [email protected] 15 Jeremy J. Barr [email protected] 16 School of Biological Sciences, Monash University 17 25 Rainforest Walk, 18 Clayton, 3800, VIC 19 Australia 20 21 Abstract 22 Carbapenem-resistant Acinetobacter baumannii is responsible for frequent, hard-to-treat and often fatal 23 healthcare-associated infections. Phage therapy, the use of viruses that infect and kill bacteria, is an approach 24 gaining significant clinical interest to combat antibiotic-resistant infections. However, a major limitation is that 25 bacteria can develop resistance against phages. Here, we isolated phages with activity against a panel of A. -
Glycoconjugates
Background Information on Glycoconjugates Richard D. Cummings, Ph.D. Director, National Center for Functional Glycomics Professor Department of Surgery Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA 02114 Tel: (617) 735-4643 e-mail: [email protected] For General Reference On-Line See: Essentials of Glycobiology (2nd Edition) Varki, Cummings, Esko, Freeze, Stanley, Bertozzi, Hart and Etzler) http://www.ncbi.nlm.nih.gov/books/NBK1908/ Mammalian Cells are Covered with Glycoconjugates GLYCOSAMINOGLYCANS/ GLYCOPROTEINS PROTEOGLYCANS GLYCOLIPIDS NUCLEAR/CYTOPLASMIC GLYCOPROTEINS 2 Mammalian Glycoconjugates are Recognized by a Wide Variety of Specific Proteins GLYCAN-BINDING PROTEIN (GBP) GBP ANTIBODY TOXIN GBP GBP VIRUS 7 ANTIBODY GBP MICROBE TOXIN 3 Glycosylation Pathways 4 Glycosylation Pathways 5 Glycoconjugates, Which are Molecules Containing Sugars (Monosaccharides) Linked Within Them, are the Major Constituents of Animal Cell Membranes (Glycocalyx) and Secreted Material: See Different Classes of Glycoconjugates Below in Red Boxes PROTEOGLYCANS GLYCOSAMINOGLYCANS GLYCOSAMINOGLYCANS GLYCOPROTEINS GPI-ANCHORED GLYCOPROTEINS GLYCOLIPIDS outside Cell Membrane cytoplasm Essentials of Glycobiology, 3rd Edition CYTOPLASMIC GLYCOPROTEINS Chapter 1, Figure 6 Glycans are as Ubiquitous as DNA/RNA and Appear to Represent Greater Molecular Diversity 7 Big Picture: Nucleotide Sugars Connection of • UDP-Glc, • UDP-Gal, • UDP-GlcNAc, Glycoconjugate • UDPGalNAc, • UDP-GlcA, Biosynthesis • UDP-Xyl, • GDP-Man, • GDP-Fuc, to Intermediary • CMP-Neu5Ac used for synthesizing Metabolism glycoconjugates, e.g, glycoproteins & glycolipids 8 Important Topics to Consider 1. The different types of monosaccharides found in animal cell glycoconjugates 2. The different types of glycoconjugates and their differences, e.g. glycoproteins, glycolipids 3. The nucleotide sugars, glycosyltransferases, glycosidases, transporters, endoplasmic reticulum, and Golgi in terms of their roles in glycoconjugate biosynthesis and turnover 4. -
Collagen-Based Matrix Matrix Auf Der Basis Von Kollagen Matrice À Base De Collagène
Europäisches Patentamt *EP000693523B1* (19) European Patent Office Office européen des brevets (11) EP 0 693 523 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.7: C08H 1/06, A61L 27/00, of the grant of the patent: A61L 31/00 20.11.2002 Bulletin 2002/47 (21) Application number: 95111260.6 (22) Date of filing: 18.07.1995 (54) Collagen-based matrix Matrix auf der Basis von Kollagen Matrice à base de collagène (84) Designated Contracting States: • Noff, Matityahu AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL Rehovot 76228 (IL) PT SE (74) Representative: Grünecker, Kinkeldey, (30) Priority: 19.07.1994 IL 11036794 Stockmair & Schwanhäusser Anwaltssozietät Maximilianstrasse 58 (43) Date of publication of application: 80538 München (DE) 24.01.1996 Bulletin 1996/04 (56) References cited: (73) Proprietor: COL-BAR R & D LTD. DE-A- 4 302 708 FR-A- 2 679 778 Ramat-Gan 52290 (IL) US-A- 4 971 954 (72) Inventors: Remarks: • Pitaru, Sandu The file contains technical information submitted Tel-Aviv 62300 (IL) after the application was filed and not included in this specification Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention). EP 0 693 523 B1 Printed by Jouve, 75001 PARIS (FR) EP 0 693 523 B1 Description [0001] The present invention concerns a collagen-based matrix and devices comprising this matrix. -
Intermediate Transfer Type Ink Jet Recording Method
Europaisches Patentamt J European Patent Office © Publication number: 0 606 490 A1 Office europeen des brevets EUROPEAN PATENT APPLICATION published in accordance with Art. 158(3) EPC © Application number: 93914949.8 int. ci.5: B41J 2/01 @ Date of filing: 02.07.93 © International application number: PCT/JP93/00914 © International publication number: WO 94/01283 (20.01.94 94/03) © Priority: 02.07.92 JP 175384/92 Inventor: HOSONO, Yoshie 02.07.92 JP 175385/92 Seiko Epson Corporation, 02.07.92 JP 175386/92 3-5, Owa 3-chome 02.07.92 JP 175387/92 Suwa-shi, Nagano 392(JP) 16.10.92 JP 278938/92 Inventor: NAKAMURA, Hiroto 05.11.92 JP 296109/92 Seiko Epson Corporation, 05.11.92 JP 296110/92 3-5, Owa 3-chome 05.11.92 JP 296111/92 Suwa-shi, Nagano 392(JP) 06.01.93 JP 665/93 Inventor: KOIKE, Yoshiyuki Seiko Epson Corporation, © Date of publication of application: 3-5, Owa 3-chome 20.07.94 Bulletin 94/29 Suwa-shi, Nagano 392(JP) Inventor: MATSUZAKI, Makoto @ Designated Contracting States: Seiko Epson Corporation, CH DE FR GB IT LI NL SE 3-5, Owa 3-chome Suwa-shi, Nagano 392(JP) © Applicant: SEIKO EPSON CORPORATION Inventor: UEHARA, Fumie 4-1, Nishishinjuku 2-chome Seiko Shinjuku-ku Tokyo 163(JP) Epson Corporation, 3-5, Owa 3-chome © Inventor: FUJINO, Makoto Suwa-shi, Nagano 392(JP) Seiko Epson Corporation, Inventor: ISHIBASHI, Osamu 3-5, Owa 3-chome Seiko Epson Corporation, Suwa-shi, Nagano 392(JP) 3-5, Owa 3-chome Inventor: KUMAGAI, Toshio Suwa-shi, Nagano 392(JP) Seiko Epson Corporation, 3-5, Owa 3-chome Suwa-shi, Nagano 392(JP) © Representative: Lewin, John Harvey Inventor: TSUKAHARA, Michinari Elkington and Fife Seiko Epson Corporation, Prospect House CO 8 Pembroke Road o 3-5, Owa 3-chome CO Suwa-shi, Nagano 392(JP) Sevenoaks, Kent TN13 1XR (GB) &) INTERMEDIATE TRANSFER TYPE INK JET RECORDING METHOD. -
An In-Vitro Investigation to Determine the Neuroinflammatory Response of CNS Cells to Oral Bacteria and Their Virulence Factors
An in-vitro investigation to determine the neuroinflammatory response of CNS cells to oral bacteria and their virulence factors by Rahul Previn A thesis submitted in partial fulfilment for the requirements for the degree of MSc (by Research) at the University of Central Lancashire February 2013 i ACKNOWLEDGEMENTS I would like to thank the University of Central Lancashire, UK for the opportunity to undertake my postgraduate research degree. I wish to thank my Principle Investigator (PI) and Director of studies (D0S), Dean, Prof St John Crean for steering me into an interesting, and a hybrid dental-neurosciences project. His inspirational and expert guidance made the challenges of education seem more manageable. I would also like to thank Dr Peter Robinson, my Research Degrees Tutor (RDT), as without his expert help in getting through the various postgraduate degree hurdles would have been impossible. I would like to express my sincere gratitude to my supervisor, Dr Sim Singhrao for the daily guidance, advice, and patience throughout the practical work of the project. I would also like to thank Miss Sophie Poole, currently a PhD student, for ad-hoc assistance in the lab and for guidance in interpreting row data whenever she was nearby. I would like to acknowledge Prof. M. Curtis for the essential reagents I used to investigate my research question without which, my project would be incomplete. Above all, I would like to express my heartfelt gratitude to my family, especially my mother for her undying love, invaluable moral and financial support and encouragement to do well, during my time away from home. -
Bacterial Size, Shape and Arrangement & Cell Structure And
Lecture 13, 14 and 15: bacterial size, shape and arrangement & Cell structure and components of bacteria and Functional anatomy and reproduction in bacteria Bacterial size, shape and arrangement Bacteria are prokaryotic, unicellular microorganisms, which lack chlorophyll pigments. The cell structure is simpler than that of other organisms as there is no nucleus or membrane bound organelles.Due to the presence of a rigid cell wall, bacteria maintain a definite shape, though they vary as shape, size and structure. When viewed under light microscope, most bacteria appear in variations of three major shapes: the rod (bacillus), the sphere (coccus) and the spiral type (vibrio). In fact, structure of bacteria has two aspects, arrangement and shape. So far as the arrangement is concerned, it may Paired (diplo), Grape-like clusters (staphylo) or Chains (strepto). In shape they may principally be Rods (bacilli), Spheres (cocci), and Spirals (spirillum). Size of Bacterial Cell The average diameter of spherical bacteria is 0.5- 2.0 µm. For rod-shaped or filamentous bacteria, length is 1-10 µm and diameter is 0.25-1 .0 µm. E. coli , a bacillus of about average size is 1.1 to 1.5 µm wide by 2.0 to 6.0 µm long. Spirochaetes occasionally reach 500 µm in length and the cyanobacterium Accepted wisdom is that bacteria are smaller than eukaryotes. But certain cyanobacteria are quite large; Oscillatoria cells are 7 micrometers diameter. The bacterium, Epulosiscium fishelsoni , can be seen with the naked eye (600 mm long by 80 mm in diameter). One group of bacteria, called the Mycoplasmas, have individuals with size much smaller than these dimensions. -
Structures and Characteristics of Carbohydrates in Diets Fed to Pigs: a Review Diego M
Navarro et al. Journal of Animal Science and Biotechnology (2019) 10:39 https://doi.org/10.1186/s40104-019-0345-6 REVIEW Open Access Structures and characteristics of carbohydrates in diets fed to pigs: a review Diego M. D. L. Navarro1, Jerubella J. Abelilla1 and Hans H. Stein1,2* Abstract The current paper reviews the content and variation of fiber fractions in feed ingredients commonly used in swine diets. Carbohydrates serve as the main source of energy in diets fed to pigs. Carbohydrates may be classified according to their degree of polymerization: monosaccharides, disaccharides, oligosaccharides, and polysaccharides. Digestible carbohydrates include sugars, digestible starch, and glycogen that may be digested by enzymes secreted in the gastrointestinal tract of the pig. Non-digestible carbohydrates, also known as fiber, may be fermented by microbial populations along the gastrointestinal tract to synthesize short-chain fatty acids that may be absorbed and metabolized by the pig. These non-digestible carbohydrates include two disaccharides, oligosaccharides, resistant starch, and non-starch polysaccharides. The concentration and structure of non-digestible carbohydrates in diets fed to pigs depend on the type of feed ingredients that are included in the mixed diet. Cellulose, arabinoxylans, and mixed linked β-(1,3) (1,4)-D-glucans are the main cell wall polysaccharides in cereal grains, but vary in proportion and structure depending on the grain and tissue within the grain. Cell walls of oilseeds, oilseed meals, and pulse crops contain cellulose, pectic polysaccharides, lignin, and xyloglucans. Pulse crops and legumes also contain significant quantities of galacto-oligosaccharides including raffinose, stachyose, and verbascose. -
Bacterial Capsular Polysaccharides of Pathogens – a Toolbox for Vaccines and Therapeutics
In: Glycome: The Hidden Code in Biology ISBN: 978-1-53619-377-0 Editor: Dipak K. Banerjee © 2021 Nova Science Publishers, Inc. Chapter 13 BACTERIAL CAPSULAR POLYSACCHARIDES OF PATHOGENS – A TOOLBOX FOR VACCINES AND THERAPEUTICS Vamsee Veeramachineni, PhD, Shonoi A. Ming, PhD, Justine Vionnet, PhD and Willie F. Vann*, PhD Laboratory of Bacterial Polysaccharides, Center for Biologics Evaluation and Research, FDA, Silver Spring, MD, US ABSTRACT The bacterial capsule is a hydrated polysaccharide structure that covers the outermost layer of the cell wall. It is an important virulence factor and acts as armor in shielding the bacteria from a variety of environmental pressures and host immune defenses. Considerable structural diversity exits not only between capsular polysaccharides of different bacterial species, but also within the same species. While most pathogenic bacteria are encapsulated, most encapsulated bacteria are not pathogenic. As a result, understanding the structural and immunological diversity of capsules together with cellular components and machinery involved in capsule biosynthesis is paramount in developing new therapeutics to fight deadly bacterial infections. This chapter presents an overview of the capsular polysaccharide of pathogenic bacteria. This overview includes the structural diversity of capsules among virulent bacteria, the organization of capsule genetic elements, the mechanisms of capsule biosynthesis and transport, along with current technologies employed in the preparation of glycoconjugate vaccines. Keywords: bacterial virulence, capsular polysaccharide, K-antigen, capsule diversity, gram- negative bacteria, gram-positive bacteria, capsular gene organization, capsular biosynthesis, ABC transporter pathway, wzy pathway, synthase pathway, capsule transport, glycoconjugate vaccines, vaccine preparation technologies * Corresponding Author’s Email: [email protected]. -
Along the Path of Bacterial Nonulosonic Acids
Faculty of Science and Technology Along the path of bacterial nonulosonic acids A study of the bio- and in vitro synthesis of sialic acid related compounds — Marie-Josée Haglund Halsør A dissertation for the degree of Philosophiae Doctor – June 2019 Along the path of nonulosonic acids A study of the bio- and in vitro synthesis of sialic acid related compounds Marie-Josée Haglund Halsør A dissertation for the degree of Philosophiae Doctor FACULTY OF SCIENCE AND TECHNOLOGY DEPARTMENT OF CHEMISTRY June 2019 "There is a single light of science and to brighten it anywhere is to brighten it everywhere." - Unsourced, credited to Isaac Asimov. Preface “Why?”, and later “How?”. Those two questions are what led me to research, without doubt. I’ve asked them (aloud or not) every day for as long as I can remember, about practically everything. The other thing is being amazed by Nature. The diversity of every aspect and how it all functions as one, somehow. My favorite as a child were the documentaries by “le Commandant Cousteau” (the sharks!), and my dream was to be an oceanographer. I pursued that dream up until my first year of university, when I discovered biochemistry. I had already grown a liking for chemistry, and it was the only discipline that answered the “biological whys and hows” without going into physics. Biochemistry studies and does, both trying to unravel Nature’s secrets and building its own means to do so. It also uses the knowledge to improve human living conditions, at least in theory. I was sold, and here I am. -
University of Huddersfield Repository
University of Huddersfield Repository Ngehnyuiy, Ngo Hansel Characterisation of Bacterial Polysaccharides Original Citation Ngehnyuiy, Ngo Hansel (2020) Characterisation of Bacterial Polysaccharides. Doctoral thesis, University of Huddersfield. This version is available at http://eprints.hud.ac.uk/id/eprint/35297/ The University Repository is a digital collection of the research output of the University, available on Open Access. Copyright and Moral Rights for the items on this site are retained by the individual author and/or other copyright owners. Users may access full items free of charge; copies of full text items generally can be reproduced, displayed or performed and given to third parties in any format or medium for personal research or study, educational or not-for-profit purposes without prior permission or charge, provided: • The authors, title and full bibliographic details is credited in any copy; • A hyperlink and/or URL is included for the original metadata page; and • The content is not changed in any way. For more information, including our policy and submission procedure, please contact the Repository Team at: [email protected]. http://eprints.hud.ac.uk/ CHARACTERISATION OF BACTERIAL POLYSACCHARIDES NGO HANSEL NGEHNYUIY, MSc A thesis submitted to the University of Huddersfield in partial fulfilment of the requirements for the degree of Doctor of Philosophy Department of Chemical and Biological Sciences School of Applied Sciences The University of Huddersfield March 2020 i ABSTRACT A number Gram-positive bacterial strains including Lactobacillus paracasei DG, Lactobacillus salivarius CCUG44481 and Bifidobacteria breve 7017 have been known to possess probiotic properties which has led to their increasing use in commercial probiotic products.